Genetic products differentially expressed in tumors and the use thereof

Details for Australian Patent Application No. 2011256897 (hide)

Owner Ganymed Pharmaceuticals AG

Inventors Koslowski, Michael; Sahin, Ugur; Tureci, Ozlem; Fritz, Stefan; Geppert, Harald-Gerhard

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011256897

Parent 2005245593

Filing date 16 December 2011

Wipo publication date 19 January 2012

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 9/88 (2006.01) Enzymes, e.g. ligases (6.) - Lyases (4.)

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

19 January 2012 Application Open to Public Inspection

  Published as AU-A-2011256897

19 January 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011256898-Morphinan compounds

2011256896-Photothermal source of fluid pumping device driven by self photovoltaic power